Staphylococcus aureus, the major pathogen in orthopaedic and cardiac surgical site infections: A literature review

International Journal of Surgery

Volumn 6, Issue 3, 2008, Pages 238-245

  Saadatian Elahi, Mitra ^a   Teyssou, Remy ^b   Vanhems, Philippe ^a  

^a UNIVERSITÉ LYON 1   (France)

^b SANOFI PASTEUR   (France)

Author keywords

Cardiac; Orthopaedic; Staphylococcus aureus; Surgical site infection; Surveillance

Indexed keywords

ARTHROSCOPIC SURGERY; CORONARY ARTERY BYPASS GRAFT; ENDOCARDITIS; HEART SURGERY; INFECTION RISK; MEDIASTINITIS; ORTHOPEDIC SURGERY; OSTEOMYELITIS; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

ARTHROSCOPY; ENDOCARDITIS, BACTERIAL; HUMANS; MEDIASTINITIS; OSTEOMYELITIS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 44849118466     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2007.05.001     Document Type: Review

References (97)

1. Popovic J.R., and Hall M.J. 1999 National Hospital Discharge Survey. CDC Advance Data (2001) 319
2. Delgado-Rodriguez M., Gomez-Ortega A., Sillero-Arenas M., and Llorca. Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study. Infect Control Hosp Epidemiol 22 (2001) 24-30
3. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20 (1999) 250-278
4. Astagneau P., Rioux C., Golliot F., Brucker G., and INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect 48 (2001) 267-274
5. Geubbels E.L., Mintjes-de Groot A.J., van den Berg J.M., and de Boer A.S. An operating surveillance system of surgical-site infections in The Netherlands: results of the PREZIES national surveillance network. Preventie van Ziekenhuisinfecties door Surveillance. Infect Control Hosp Epidemiol 21 (2000) 311-318
6. Mertens R., Jans B., and Kurz X. A computerized nationwide network for nosocomial infection surveillance in Belgium. Infect Control Hosp Epidemiol 15 (1994) 171-179
7. Kirkland K.B., Briggs J.P., Trivette S.L., Wilkinson W.E., and Sexton D.J. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20 (1999) 725-730
8. Coello R., Charlett A., Wilson J., Ward V., Pearson A., and Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 60 (2005) 93-103
9. McGarry S.A., Engemann J.J., Schmader K., Sexton D.J., and Kaye K.S. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 25 (2004) 461-467
10. Kaye K.S., Schmit K., Pieper C., Sloane R., Kaughlan K.F., Sexton D.J., et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis 191 (2005) 1056-1062
11. Raymond D.P., Pelletier S.J., Crabtree T.D., Schulman A.M., Pruett T.L., and Sawyer R.G. Surgical infection and the aging population. Am Surg 67 (2001) 827-832
12. de Boer A.S., Mintjes-de Groot A.J., Severijnen A.J., van den Berg J.M., and van Pelt W. Risk assessment for surgical-site infections in orthopedic patients. Infect Control Hosp Epidemiol 20 (1999) 402-407
13. Malone D.L., Genuit T., Tracy J.K., Gannon C., and Napolitano L.M. Surgical site infections: reanalysis of risk factors. J Surg Res 103 (2002) 89-95
14. Vuorisalo S., Haukipuro K., Pokela R., and Syrjala H. Risk features for surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 19 (1998) 240-247
15. Espehaug B., Havelin L.I., Engesaeter L.B., Langeland N., and Vollset S.E. Patient-related risk factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop Scand 68 (1997) 207-215
16. Rapp-Kesek D., Stahle E., and Karlsson T.T. Body mass index and albumin in the preoperative evaluation of cardiac surgery patients. Clin Nutr 23 (2004) 1398-1404
17. Engelman D.T., Adams D.H., Byrne J.G., Aranki S.F., Collins Jr. J.J., Couper G.S., et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 118 (1999) 866-873
18. Pratt W.B., Veitch J.M., and McRoberts R.L. Nutritional status of orthopedic patients with surgical complications. Clin Orthop Relat Res 155 (1981) 81-84
19. Ridgeway S., Wilson J., Charlet A., Kafatos G., Pearson A., and Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 87 (2005) 844-850
20. Ku C.H., Ku S.L., Yin J.C., and Lee A.J. Risk factors for sternal and leg surgical site infections after cardiac surgery in Taiwan. Am J Epidemiol 161 (2005) 661-671
21. Barie P.S., and Eachempati S.R. Surgical site infections. Surg Clin North Am 85 (2005) 1115-1135
22. Luessenhop C.P., Higgins L.D., Brause B.D., and Ranawat C.S. Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis. J Arthroplasty 11 (1996) 862-868
23. Wilson M.G., Kelley K., and Thornhill T.S. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 72 (1990) 878-883
24. Brause B.D. Infection with prostheses in bones and joint. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. vol. 1 (2000), Churchill Livingstone, New York p. 1196-200
25. Menon T.J., and Wroblewski B.M. Charnley low-friction arthroplasty in patients with psoriasis. Clin Orthop Relat Res 176 (1983) 127-128
26. Fowler Jr. V.G., O'Brien S.M., Muhlbaier L.H., Corey G.R., Ferguson T.B., and Peterson E.D. Clinical predictors of major infections after cardiac surgery. Circulation 112 (2005) I358-I365
27. Kluytmans J.A., and Wertheim H.F. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33 (2005) 3-8
28. Kalmeijer M.D., van Nieuwland-Bollen E., Bogaers-Hofman D., and de Baere G.A. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21 (2000) 319-323
29. Haas J.P., Evans A.M., Preston K.E., and Larson E.L. Risk factors for surgical site infection after cardiac surgery: the role of endogenous flora. Heart Lung 34 (2005) 108-114
30. Herwaldt L.A. Staphylococcus aureus nasal carriage and surgical-site infections. Surgery 134 (2003) S2-S9
31. Kluytmans J.A., Mouton J.W., Ijzerman E.P., Vandenbroucke-Grauls C.M., and Maat A.W. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 171 (1995) 216-219
32. Luzar M.A., Coles G.A., Faller B., et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 322 (1990) 505-509
33. Herwaldt L.A. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 40 (1998) S13-S23
34. Sissolak D., Geusau A., Heinze G., Witte W., and Rotter M.L. Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains. Eur J Clin Microbiol Infect Dis 21 (2002) 88-96
35. Weber S., Herwaldt L.A., Mcnutt L.A., Rhomberg P., Vaudaux P., and Pfaller M. An outbreak of Staphylococcus aureus in a pediatric cardiothoracic surgery unit. Infect Control Hosp Epidemiol 23 (2002) 77-81
36. Wang J.T., Chang S.C., Ko W.J., Chang Y.Y., Chen M.L., Pan H.J., et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 47 (2001) 104-109
37. San Juan R., Aguado J.M., Lopez M.J., Lumbreras S., Enriquez F., Sanz F., et al. Accuracy of blood culture for early diagnosis of mediastinitis in febrile patients after cardiac surgery. Eur J Clin Microbiol Infect Dis 24 (2005) 182-189
38. Lesens O., Hansmann Y., Brannigan E., Remy V., Hopkins S., Martinot M., et al. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 48 (2004) 245-252
39. Gottlieb G.S., Fowler Jr. V.G., Kong L.K., McClelland R.S., Gopal A.K., Marr K., et al. Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. J Am Coll Surg 190 (2000) 50-57
40. Fowler Jr. V.G., Kaye K.S., Simel D.L., Cabell C.H., McClachlan D., Smith P.K., et al. Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation 108 (2003) 73-78
41. Mayhall C.G. Staphylococcus aureus. Hospital epidemiology and infection control. 3rd ed. (2004), Lippincott Williams & Wilkins, Baltimore
42. Janin B., Chevalley F., Raselli P., Livio J.J., and Francioli P. Prospective surveillance of nosocomial infections in a traumatology and orthopedics service. Helv Chir Acta 60 (1993) 211-218
43. Whitehouse J.D., Friedman N.D., Kirkland K.B., Richardson W.J., and Sexton D.J. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 23 (2002) 183-189
44. Hebert C.K., Williams R.E., Levy R.S., and Barrack R.L. Cost of treating an infected total knee replacement. Clin Orthop Relat Res 331 (1996) 140-145
45. O'Donoghue M.A., and Allen K.D. Costs of an outbreak of wound infections in an orthopaedic ward. J Hosp Infect 22 (1992) 73-79
46. Migaud H., Sennevill E., Amzallag M., and Laffarague P. Risque infectieux en chirurgie orthopédique. EMC-Rhumatologie Orthopédie 2 (2005) 151-172
47. Lew P., and Waldvogel F.A. Infections of skeletal prostheses. In: Bennett J.V., and Brachman P.S. (Eds). Hospital infection. 4th ed. (1998), Lippincott Raven, Philadelphia 613-620
48. Thomas C., Cadwallader H.L., and Riley T.V. Surgical-site infections after orthopaedic surgery: statewide surveillance using linked administrative databases. J Hosp Infect 57 (2004) 25-30
49. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
50. Health Protection Agency, Mandatory surveillance of SSI in orthopaedic surgery, England 2004-2005.
51. Caillet-vallet E., Bernet C., Hajjar J., Ayzac L., and Fabry J. Réseau de surveillance des infections du site opératoire. Iso Sud-est, Rapport général (2003). http://cclin-sudest.chu-lyon.fr
52. HELICS. Hospital in Europe Link for Infection Control though Surveillance. http://helics.univ-lyon1.fr
53. Schneeberger P.M., Smits M.H., Zick R.E., and Wille J.C. Surveillance as a starting point to reduce surgical-site infection rates in elective orthopaedic surgery. J Hosp Infect 51 (2002) 179-184
54. Stefanovski N., and Van Voris L.P. Pyogenic vertebral osteomyelitis: report of a series of 23 patients. Contemp Orthop 31 (1995) 159-164
55. McHenry M.C., Easley K.A., and Locker G.A. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis 34 (2002) 1342-1350
56. Dimar J.R., Carreon L.Y., Glassman S.D., Campbell M.J., Hartman M.J., and Johnson J.R. Treatment of pyogenic vertebral osteomyelitis with anterior debridement and fusion followed by delayed posterior spinal fusion. Spine 29 (2004) 326-332
57. Babcock H.M., Carroll C., Matava M., L'ecuyer P., and Fraser V. Surgical site infections after arthroscopy: Outbreak investigation and case control study. Arthroscopy 19 (2003) 172-181
58. Fry D.E. The economic costs of surgical site infection. Surg Infect 3 (2002) S37-S43
59. Lepelletier D., Perron S., Bizouarn P., Caillon J., Drugeon H., Michaud J.L., et al. Surgical-site infection after cardiac surgery: incidence, microbiology, and risk factors. Infect Control Hosp Epidemiol 26 (2005) 466-472
60. Immer F.F., Durrer M., Muhlemann K.S., Erni D., Gahl B., and Carrel T.P. Deep sternal wound infection after cardiac surgery: modality of treatment and outcome. Ann Thorac Surg 80 (2005) 957-961
61. Upton A., Roberts S.A., Milsom P., and Morris A.J. Staphylococcal post-sternotomy mediastinitis: five year audit. Aust NZ J Surg 75 (2005) 198-203
62. Tang G.H., Maganti M., Weisel R.D., and Borger M.A. Prevention and management of deep sternal wound infection. Semin Thorac Cardiovasc Surg 16 (2004) 62-69
63. Crabtree T.D., Codd J.E., Fraser V.J., Bailey M.S., Olsen M.A., and Damiano Jr. R.J. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg 16 (2004) 53-61
64. Sharma M., Berriel-Cass D., and Baran Jr. J. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 25 (2004) 468-471
65. Harrington G., Russo P., Spelman D., Borrell S., Watson K., Barr W., et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 25 (2004) 472-476
66. Gummert J.F., Barten M.J., Hans C., Kluge M., Doll N., Walther T., et al. Mediastinitis and cardiac surgery-an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg 50 (2002) 87-91
67. Baskett R.J., MacDougall C.E., and Ross D.B. Is mediastinitis a preventable complication? A 10-year review. Ann Thorac Surg 67 (1999) 462-465
68. Borger M.A., Rao V., Weisel R.D., Ivanov J., Cohen G., Scully H.E., et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg 65 (1998) 1050-1056
69. Toumpoulis I.K., Anagnostopoulos C.E., Derose Jr. J.J., and Swistel D.G. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest 127 (2005) 464-471
70. Force S.D., Miller D.L., Petersen R., Mansour K.A., Craver J., Guyton R.A., et al. Incidence of deep sternal wound infections after tracheostomy in cardiac surgery patients. Ann Thorac Surg 80 (2005) 618-621
71. Curtis J.J., Clark N.C., McKenney C.A., Walls J.T., Schmaltz R.A., Demmy T.L., et al. Tracheostomy: a risk factor for mediastinitis after cardiac operation. Ann Thorac Surg 72 (2001) 731-734
72. Sakamoto H., Fukuda I., Oosaka M., and Nakata H. Risk factors and treatment of deep sternal wound infection after cardiac operation. Ann Thorac Cardiovasc Surg 9 (2003) 226-232
73. Meune C., Arnal C., Hermand C., and Cocheton J.J. Infective endocarditis related to pacemaker leads. A review. Ann Med Interne (Paris) 151 (2000) 456-464
74. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
75. Chastre J., and Trouillet J.L. Early infective endocarditis on prosthetic valves. Eur Heart J 16 Suppl. B (1995) 32-38
76. Chirouze C., Cabell C.H., Fowler Jr. V.G., Khayat N., Olaison L., Miro J.M., et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis 38 (2004) 1323-1327
77. Hudson M.C., Ramp W.K., and Frankenburg K.P. Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials. FEMS Microbiol Lett 173 (1999) 279-284
78. Gracia E., Fernandez A., Conchello P., Lacleriga A., Paniagua L., Seral F., et al. Adherence of Staphylococcus aureus slime-producing strain variants to biomaterials used in orthopaedic surgery. Int Orthop 21 (1997) 46-51
79. Miller L.S., O'Connell R.M., Gutierrez M.A., Pietras E.M., Shahangian A., Gross C.E., et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24 (2006) 79-91
80. Verdrengh M., Thomas J.A., and Hultgren O.H. IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection. Microbes Infect 6 (2004) 1268-1272
81. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165 (2000) 5392-5396
82. Perl T.M., Cullen J.J., Wenzel R.P., Zimmerman M.B., Pfaller M.A., Sheppard D., et al. Mupirocin And The Risk Of Staphylococcus aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002) 1871-1877
83. Martorell C., Engelman R., Corl A., and Brown R.B. Surgical site infections in cardiac surgery: an 11-year perspective. Am J Infect Control 32 (2004) 63-68
84. VandenBergh M.F., Kluytmans J.A., van Hout B.A., Maat A.P., Seerden R.J., McDonnel J., et al. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 17 (1996) 786-792
85. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., Bogaers-Hofman D., de Baere G.A., Stuurman A., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35 (2002) 353-358
86. Davey P. Eradication of nasal carriage of Staphylococcus aureus-is it cost-effective?. J Hosp Infect 40 (1998) S31-S37
87. American Dental Association; American Academy of Orthopedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements. J Am Dent Assoc 134 (2003) 895-899
88. Engemann J.J., Carmeli Y., Cosgrove S.E., Fowler V.G., Bronstein M.Z., Trivette S.L., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36 (2003) 592-598
89. Douglas P., Asimus M., Swan J., and Spigelman A. Prevention of orthopaedic wound infections: a quality improvement project. J Qual Clin Pract 21 (2001) 149-153
90. van Kasteren M.E., Mannien J., Kullberg B.J., de Boer A.S., Nagelkerke N.J., Ridderhof M., et al. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J Antimicrob Chemother 56 (2005) 1094-1102
91. Gastmeier P., Sohr D., Brandt C., Eckmanns T., Behnke M., and Ruden H. Reduction of orthopaedic wound infections in 21 hospitals. Arch Orthop Trauma Surg 125 (2005) 526-530
92. Surveillance des infections du site opératoire en France en 2003, Réseau Alerte Investigation Surveillance des Infections. Rapport Iso-Raisin (2003). http://www.fc-sante.atrium.rss.fr/cclin-est/surveil_ISO.shtml
93. Medina-Cuadros M., Sillero-Arenas M., Martinez-Gallego G., and Delgado-Rodriguez M. Surgical wound infections diagnosed after discharge from hospital: epidemiologic differences with in-hospital infections. Am J Infect Control 24 (1996) 421-428
94. Fields C.L. Outcomes of a postdischarge surveillance system for surgical site infections at a Midwestern regional referral center hospital. Am J Infect Control 27 (1999) 158-164
95. Mitchell D.H., Swift G., and Gilbert G.L. Surgical wound infection surveillance: the importance of infections that develop after hospital discharge. Aust NZ J Surg 69 (1999) 117-120
96. Fanning C., Johnston B.L., MacDonald S., LeFort-Jost S., and Dockerty E. Postdischarge surgical site infection surveillance. Can J Infect Control 10 (1995) 75-79
97. Manian F.A., and Meyer L. Comparison of patient telephone survey with traditional surveillance and monthly physician questionnaires in monitoring surgical wound infections. Infect Control Hosp Epidemiol 14 (1993) 216-218